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Rapport de synthèse 
Introduction : La prise en charge des patients critiques nécessite dans la majorité des situations 
l'obtention rapide d'un accès vasculaire, afin d'administrer des médicaments, des solutés de 
remplissage, ou des produits sanguins. La mise en place d'un accès vasculaire peut s'avérer difficile 
chez ces patients. En cas d'échec de pose d'une voie veineuse périphérique, des abords vasculaires 
alternatifs existent. Il s'agit essentiellement de la pose d'une voie veineuse centrale, la réalisation 
d'une dénudation veineuse, ou la pose d'une voie intra-osseuse. Depuis le développement de 
dispositifs d'insertion « semi-automatique » à la fin des années 90, la voie intra-osseuse, 
traditionnellement réservée aux cas pédiatriques, est de plus en plus fréquemment utilisée chez les 
patients adultes. Le Service des Urgences du CHUV a introduit en 2009 les dispositifs d'insertion 
d'aiguilles intra-osseuses de type EZ-10® (perceuse électrique), en salle de réanimation des urgences 
vitales (déchoquage), ainsi qu'au sein du secteur préhospitalier pour les interventions du SMUR de 
Lausanne et de l'hélicoptère REGA de la base de Lausanne. Par cette étude, nous voulions mettre en 
évidence les aspects épidémiologiques des patients ayant dû être perfusés par cet abord dans un 
contexte préhospitalier, ainsi que les circonstances cliniques ayant justifié un tel usage, le taux de 
succès, les éventuelles complications, les médicaments perfusés et la mortalité des patients ayant 
bénéficié de ce dispositif. 
Méthode: Chaque patient ayant bénéficié de la mise en place d'une voie intra-osseuse par EZ-10® du 
1er janvier 2009 au 31 décembre 2011 a été inclus. Les données récoltées étaient l'âge, le sexe, 
l'indication à la mise en place de l'intra-osseuse, la localisation, le taux de succès, les médicaments et 
fluides administrés, les complications, la mortalité à 48 heures et à la sortie de l'hôpital. 
Tous les articles mentionnant l'utilisation de l'EZ-10® dans des situations cliniques ont également été 
analysés par une revue de littérature structurée exhaustive, afin de comparer nos résultats avec les 
données de la littérature. 
Résultats : Cinquante-huit patients, représentant 60 intra-osseuses EZ-10®, ont été inclus. Leur âge 
moyen (47 ans), le taux de succès (90%), les indications, la localisation de l'aiguille (98% au niveau 
du tibia proximal) et le taux de complications (0%) correspondent aux valeurs trouvées dans la 
littérature. Le taux de survie de nos patients est de 38% à 48 heures et de 29% à la sortie de l'hôpital. 
De nombreux médicaments ou solutés de perfusion ont été administrés; l'adrénaline restant le 
médicament le plus fréquemment administré par cette voie. Dans 7 cas, les patients ont bénéficié 
d'une induction d'anesthésie par voie intra-osseuse. La revue de littérature a permis de compiler 30 
études distinctes, représentant un total de 1603 accès vasculaires de type EZ-10®. 
Conclusion : La voie intra-osseuse s'avère fiable et rapide pour obtenir un accès vasculaire, avec un 
taux de complications très faible et permet l'administration d'un grand nombre de substances. 
D'autres études sont nécessaires pour évaluer l'impact de la voie intra osseuse, notamment en 
termes de mortalité, de complications tardives, ainsi que d'analyse coûUbénéfice de ce matériel. 
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Introduction: Intraosseous access is increasingly recognised as an effective alternative vascular access 
to peripheral venous access. We aimed to prospectively study the patients receiving prehospital 
intraosseous access with the EZ-10®, and to compare our results with those of the available literature. 
Metlwds: Every patient who required an intraosseous access with the EZ-10 from january 1 st, 2009 to 
December 31st, 2011 was inc!uded. The main data collected were: age, sex, indication for intraosseous 
access, localisation of insertion, success rate, drugs and fluids administered, and complications. Ali pub-
lished studies concerning the EZ-10 device were systematically searched and reviewed for comparison. 
Resu/ts: Fifty-eight patients representing 60 EZ-10 procedures were included. Mean age was 4 7 years 
(range 0.5-91 ), and the success rate was 90%. The main indications were cardiorespiratory arrest (74%), 
major trauma ( 12%), and shock ( 5%). The anterior tibia was the main route. The main drugs administered 
were adrenaline ( epinephrine ), atropine and amiodarone. No complications were reported. We identified 
30 heterogeneous studies representing 1603 EZ-10 insertions. The patients' characteristics and success 
rate were simi!ar to our study. Complications were reported in 13 cases ( 1.3%). 
Conclusion: The EZ-10 provides an effective way to achieve vascular access in the pre-hospital setting. 
Our results were similar to the cumulative results of al! studies involving the use of the EZ-10, and that 
can be used for comparison for further studies. 
1. Introduction 
Rapid intravascular access is frequently required in order to 
administer emergency drugs or fluids in critical patients. Peripheral 
venous cannulation remains the standard of care, but may be alto-
gether difficult to achieve and time-consuming in life-threatening 
situations. Intraosseous (IO) access is increasingly recognised as 
an effective alternative to peripheral venous cannulation. The IO 
access is characterised by a rapid learning curve and an effec-
tiveness equivalent to peripheral venous cannulation in terms of 
pharmacokinetic and clinical efficacy.1•2 Initially used in children, 
IO access has been implemented progressively with good results 
in the adult population, particularly since the development of the 
semi-automatic insertion devices in the late 90s, which may be 
more effective than manual JO techniques.3 Since 2010, IO access 
became a standard of care in adult advanced life support and the 
first recommended alternative to peripheral venous cannulation 
* A Spanish translated version of the abstract of this article appears as Appendix 
in the final online version at http://dx.doi.org/10.1016/j.resuscitation.2012.11.006. 
* Corresponding author at: Emergency Service, University Hospital Center Lau-
sanne, 1011 Lausanne, Switzerland. Tel.: +4179353 80 29; 
fax: +41 2131408 71. 
E-mail address: David.Santos.Pinto@gmail.com (D. Santos). 
0300-9572/$ - see front matter © 2012 Elsevier lreland Ltd. Ali rights reserved. 
http://dx.doi.org/10.1016/j.resuscitation.2012.11.006 
© 2012 Elsevier lreland Ltd. Ali rights reserved. 
in cardiac arrest patients.4 Contraindications include orthopaedic 
hardware, infection at the site of insertion, traumatic extensive 
limb injuries, amputation of a limb and osseous pathologies such 
as osteogenesis imperfecta.5 
The EZ-10®, a new power drill semi-automatic device, has been 
introduced over the last ten years. To date, several articles about 
the EZ-JO device use have been published. They are mainly focused 
on the success rate and rapidity of insertion, but there is limited 
information about the complications and outcomes of patients in 
whom an intraosseous access has been attempted. 
We prospectively studied the indications, localisations, medi-
cations administered and success rate of achieving intraosseous 
access with the EZ-10 in a physician-based pre-hospital setting. The 
complications and mortality rate of patients were also recorded. At 
the same time, ail the published studies involving the EZ-IO device 
in the emergency setting were systematically reviewed in order to 
compare the results of our study, and to inventory ail drugs and 
fluids administered by this route. 
2. Methods 
2.1. Study design and setting 
This prospective study was conducted from january lst, 2009 
to December 31st, 2011, in the pre-hospital emergency medical 
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service (EMS) of the Centre Hospitalier Universitaire Vaudois 
(CHUV). The CHUV is a 1000-bed university hospital located in 
Lausanne, Switzerland, and is the level 1 Trauma Centre and Burn 
Centre for a population of over one million people in the western 
part of the country. It is also the primary hospital for an imme-
diate catchment area comprising about 300 000 persans. Road 
ambulances staffed with paramedics are the primary response 
of the pre-hospital emergency services. Emergency physicians 
may be sent on site by ground (emergency resuscitation vehicles) 
or by air (rescue helicopter) under specific indications such as 
airway obstruction, cardiac arrest, respiratory distress, shock, 
major trauma, severe burns, or by request from paramedics on site. 
Emergency physicians are engaged in about 3000 interventions 
annually; trauma-related emergencies represent 15% of ail cases. 
2.2. Study instrument and operators 
The EZ-10® (Vidacare Corp., Shavano Park, TX) is a battery-
powered driver with a needle set. Three types of needles are 
available: one paediatric (15 G/15 mm) and two adult (15 G/25 mm 
and 15 G/45 mm) sizes. Sin ce 2008, the EZ-IO has become a standard 
of care in our pre-hospital emergency resuscitation vehicles and in 
the rescue helicopter. The operators are pre-hospital emergency 
physicians trained in the use of the EZ-IO device during a 1-h the-
oretical and practical session. 
2.3. Inclusion and exclusion criteria 
An intraosseous EZ-IO access attempt was recommended after 
two unsuccessful peripheral intravenous catheter attempts in 
ail critical patients requiring advanced resuscitation procedures. 
These procedures were defined as follows: cardiopulmonary 
resuscitation, fluid resuscitation, emergency drugs administration, 
anaesthesia induction, or major analgesia. Ali adult and paedi-
atric patients who had undergone an intraosseous insertion were 
included. There were no exclusion criteria. Placement was con-
sidered successful if the needle was fixed firmly in the bone after 
insertion, along with the possibility of infusing a 5 ml saline bolus 
without resistance. The Institutional Review Board and the Ethics 
Committee of the Faculty of Medicine of the University of Lausanne 
approved the study. 
2.4. Measurements 
The following data were collected: age, sex, indication for JO 
access, history of drug abuse (anamnestic or clinical), localisation 
of IO insertion and success of insertion. The drugs and fluids admin-
istered (types and doses) through the IO route were gathered. 
Immediate complications related to the insertion of the EZ-10 (fluid 
extravasation, dislodgements, fracture related to the JO procedure) 
were collected, as well as delayed complications (local infection, 
extensivE; soft tissue lesion) at 48 h or at discharge from hospital. 
Mortality during the first 48 h and mortality at hospital discharge 
were also evaluated. 
2.5. Review of the literature 
We searched the literature for ail published studies and 
reports involving EZ-IO use in humans. Ali articles that described 
any administration of drugs, fluids or blood products through 
the IO route were also selected. The Medline and Cochrane 
Library databases were last consulted on October 25th, 2012, 
with no restriction to language. The following entry terms were 
used: intraosseous [Mesh] and EZ-10. The selected articles where 
searched for additional references. 
2.6. Statistical analysis 
Descriptive statistics of the study sample and of the review 
of the literature were used to represent the mean and median 
with standard deviation or number and percentage as appropri-
ate. Data analysis was done using Microsoft Excel (Microsoft Corp., 
Redmond, WA) and STATA (Stata Statistical Software 11.0, Stata 
Corporation, College Station, TX, USA). 
3. Results 
Among the 8378 patients who required an emergency physician 
intervention during the study period, 58 patients (0.7%) met the 
inclusion criteria, representing 60 EZ-IO insertion attempts (two 
patients each underwent two intraosseous insertion attempts). 
3.1. Characteristics of study subjects 
Forty patients were male (69%), with a mean age of 47 (range 
0.5-91 ). Fourteen patients (24%) were aged 16 or under. In seven 
cases, the pre-hospital emergency physician placed the EZ-IO dur-
ing transport to the hospital (n = 7). 
Table 1 
List of drugs and fluids administered through the EZ-10. 
Acteplase 
Adrenaline' (epinephrine) (35) 
Adenosine 
Amiodarone' (6) 
Atropine' ( 19) 
Bicarbonate 
Calcium 
Cefazolin 
Ceftriaxone 
Cisatracurium 
Cordarone 
Cristalloids' ( 58) 
Dopamine 
Enoxaparin 
Ephedrine' (3) 
Etomidate' (5) 
Factor Vila 
Fentanyl' (6) 
Flumazenil 
Furosemide' ( 1) 
Glucose' (2) 
Haloperidol 
Heparin 
Hydroxocobalamin 
Ketamine' (2) 
Labetalol 
Lidocaine' ( 3) 
Magnesium 
Methylprednisolone 
Midazolam' (6) 
Morphine' (1) 
Naloxone' (1) 
Omeprazole 
Packed red blood cells' (1) 
Phenylephrine' ( 1) 
Potassium chloride 
Propofol 
Rocuronium' ( 1) 
Salycilic acid' {3) 
Sodium bicarbonate 
Sufentanyl 
Suxametonium' (7) 
Tenecteplase 
Vecuronium' (2) 
a Drugs given in our cohort (number of patients). 
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3.2. Success rate and indication for intraosseous access 
Intraosseous needle access was successful in 54 of the 60 inser-
tion attempts (90%). The reasons for failure were impossibility to 
infuse in three patients, difficulty in inserting the needle in two, and 
one case ofwrong location (IO placed in the tibial plateau). Indica-
tions for IO access were: cardiorespiratory arrest from presumed 
cardiac origin (n=36, 62% of the 58 patients), traumatic cardiac 
arrest (n = 7, 12%), majortrauma (n = 7, 12%), shock (n =3, 5%), acute 
respiratory distress (n = 2, 3%), severe hypoglycemia (n = 2, 3%), 
and status epilepticus (n = 1, 2%). Four patients (7%) were IV drug 
abusers. 
3.3. Site of puncture 
Fifty-nine EZ-IO (98%) were placed in the anterior proximal tibia, 
including one that was inserted in the tibial plateau. One EZ-IO was 
placed in the humerai head (avalanche rescue situation). 
3.4. Medications 
Resuscitation drugs were the most frequently administered 
drugs through the intraosseous route: adrenaline (epinephrine) 
in 35 cases (60%, median dose 2.3mg, range 0.15-10), atropine 
in 19 cases (32%), and amiodarone in 6 cases (10%). Crystalloids 
were administered to all patients, with a mean volume of 503 ml 
431 records identified through database searching 
• 422 Medline (29 EZ-10; 393 intraosseous 
[Mesh]) 
• 9 Cochrane library (0 EZ-10; 9 
intraosseous) 
1 410 records remained after removal of duplicates 
410 records screened using title and abstract 
145 full-text articles reviewed 
' 
30 EZ-10 studies included in qualitative synthesis 
• 12 case reports or case series 
• 12 prospective observational studies 
• 3 retrospective studies 
• 3 randomised controlled studies 
(SD 276.29). Seven rapid-sequence inductions were performed (all 
with etomidate and succinylcholine), as well as four major analge-
sias using either fentanyl or ketamine. The intraosseous access was 
used only once to administer red blood packed cells. Ali medica-
tions used are Iisted in Table 1. In seven cases, nothing other than 
fluids was administered through the EZ-IO. 
3.5. Morbidity/mortality 
No immediate complications occurred. Twenty-two patients 
survived at 48 h (38%) and 17 were discharged from the hospital 
(29%). Five (11%) of the 43 patients who had had cardiac arrestwere 
discharged from the hospital. No complications were reported at 
hospital discharge in the 17 survivors. 
3.6. Resu/ts of the literature review 
The Iiterature review identified 30 studies reporting the use of 
the EZ-IO device (Fig. 1 ). These studies were heterogeneous in their 
design and consisted of 12 case reports, 12 prospective studies, 
three retrospective studies, and three randomised controlled trials 
(Table 2).6-35 Overall, 1585 intraosseous needles were inserted 
in 1603 patients. Needles were inserted by paramedics, nurses or 
physicians, bath in the pre-hospital and in-hospital setting and 
both in civilian and warfare contexts. In most European studies, 
EZ-IO insertion was performed by physicians, whereas in most 
21 duplicate records excluded 
1 
265 records excluded 
• 94 not relevant 
• 81 animal/cadaver/simulation studies 
• 64 review articles/editorials/comments 
• 15 language (5 Chinese, 4 Russian, 2 ~ Danish, 1 ltalian, 1 Turkish, 1 Czech, 1 Dutch) 
• 6 non-EZ-10 studies 
• 2 EZ-10 used in a non-emergency 
situation 
• 2 EZ-10 not in emergent situation 
• 1 multiple publication of same study 
~ 115 full-text articles excluded 
• 72 non-EZ-10 studies 
• 42 review articles/editorials/comments 
• 1 EZIO used in a non-emergency 
situation 
Fig. 1. Literature review flow diagram. 
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Tabie2 
Literature review. 
Publication 
Torres et aJ.18 
Landy etaJ.6 
Tan et al.19 
Leidel et aJ.33 
Wampler et aJ.30 
Myers et al.31 
Cotte et al.7 
Schalk et aJ.20 
Reades et aJ.34 
Knuth et al.8 
Ruiz-Hornillos et aI.9 
Chatterjee et al. 10 
Gazin et al.21 
Reades et ar.22 
Sunde et aJ.32 
WerneretaJ.11 
Leidel et aJ.35 
Truhlar et aI.12 
Burgert13 
Paxton et aI.23 
Tsung et aJ.14 
Sarkar et al.15 
Frascone et ar.2• 
Ong et aJ.25 
Langley et aI.16 
Horton et aJ.26 
Cooper et aI.17 
Frascone et aJ.27 
Davidoff et aJ.28 
GillumetaI.29 
Overall 
Santos eta!. 
NM = not mentioned. 
Trial type 
Prospective 
observational 
Case report 
Prospective 
observational 
Randomised 
controlled 
Retrospective 
Retrospective 
Case report 
Prospective 
observational 
Randomised 
controlled 
Case report 
Case report 
Case report 
Prospective 
observational 
Prospective 
observational 
Retrospective 
Case report 
Randomised 
controlled 
Case series 
Case report 
Prospective 
observational 
Ca~e series 
Case report 
Prospective 
observational 
Prospective 
observational 
Case report 
Prospective 
observational 
Case series 
Prospective 
observational 
Prospective 
observational 
Prospective 
observational 
Prospective 
observational 
Cases (n) 
107 (11410) 
1 
42 
40 (BIG+EZ-10) 
244 
60(6210) 
1 
77 
115 
39 
88 
49 
20 
22 
30 
3 
1 (310) 
19 
35 
2 
95 
26 (3310) 
89 
250 
125 
1585 patients 
(160310) 
58(6010) 
Age 
(mean) 
56.5 
53 
NM 
48 
63 
0.98 
57 
66 
64 
48 
64 
38 
57 
63 
NM 
76 
43 
NM 
79 
46.9 
29.4 
19 
1.5 
NM 
48 
5.5 
NM 
55.1 
NM 
61 
51.3 
47.2 
Cardia respiratory 
arrest (%(n)) 
67(72) 
100 (1) 
NM 
NM 
100 (244) 
70 (42) 
0 
56 (41) 
100(115) 
0 
100 (1) 
0 
76(30) 
100 (88) 
NM 
0 
NM 
32 (7) 
0 
6(2) 
100(3) 
0 
52(10) 
NM 
0 
NM 
NM 
NM 
NM 
82 (102) 
758/939 = 81 % 
74(43) 
Major trauma 
(%(n)) 
40 (43) 
0 
50 (21) 
73 (29) 
NM 
5 (3) 
0 
20 (15) 
0 
100 (1) 
0 
0 
0 
0 
NM 
0 
70 (14) 
40(9) 
0 
33 (10) 
0 
100 (1) 
16 (3) 
23 (8) 
50 (1) 
31 (30) 
96 (25) 
NM 
24(60) 
10(13) 
Paediatrics 
(%(n)) 
NM 
0 
0 
0 
NM 
100 (60) 
0 
7 (5) 
0 
0 
0 
0 
12 (5) 
0 
NM 
0 
0 
40(9) 
0 
0 
33 (1) 
0 
100 (19) 
0 
0 
100 (95) 
30 (10) 
0 
0 
0 
286/1203 =24% 204/1185= 17% 
26 (15) 24 (14) 
Tibial localisation 
(%(n)) 
74(85) 
100 (1) 
47(20) 
45 (18) 
0(244) 
NM 
100 (1) 
100 (77) 
55 (64) 
0 
100 (1) 
0 
NM 
66 (58) 
NM 
100 (1) 
45 (9) 
NM 
100 (1) 
100 (30) 
NM 
33 (1) 
100 {19) 
69 (24) 
100 (2) 
NM 
NM 
100 (89) 
100 (250) 
100 (125) 
1120/1298=86% 
98 (58) 
Success (%(n)) 
100 (114) 
100 (1) 
93(39) 
85(34) 
93(227) 
87 (54) 
100 (1) 
97(75) 
71 (82) 
100 (1) 
100 (1) 
100 (1) 
85 (33) 
69 (61) 
96(47) 
100 (1) 
90 (18) 
95 (21) 
100 (1) 
97(29) 
67 (2) 
67 (2) 
95 (18) 
100 (35) 
100(2) 
94(89) 
94(31) 
88 (78) 
97(242) 
94 (118) 
1458/1603=91% 
90(54) 
Complications IO (%(n)) 
0 
100 (1) 
NM 
0 
NM 
0 
100 (1) 
NM 
NM 
0 
0 
0 
0 
0 
4 ( 1 displacement 1 
extravasation) 
0 
10 (2 extravasations) 
0 
0 
NM 
0 
0 
26 (2 extravasation, 2 
impossibility to infuse 
1 dislodgment) 
0 
0 
0 
0 
NM 
0.8 (2 displacements) 
0 
13/995 = 1.3% 
0 
Induction of 
anaesthesia 
0 
0 
0 
NM 
NM 
NM 
0 
0 
0 
0 
0 
2 
0 
0 
0 
0 
0 
4 
0 
0 
0 
NM 
1 
NM 
4 
0 
NM 
NM 
13 
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American studies, paramedics inserted the device. The reported 
drugs, electrolytes or blood products administered through the 
EZ-IO needle are presented in Table 1. The most frequent drug 
administered was adrenaline. Only one study reports survival at 
discharge; 13 patients (or 5.4% of ail patients) survived among 
a cohort of patients with cardio-respiratory arrest on which the 
EZ-IO had been inserted in the humerus by paramedics.30 
4. Discussion 
The predominance of males among our study subjects is consis-
tent with the findings of other studies, and is most likely explained 
by the large proportion of cardio-respiratory arrests and major 
trauma situations. The 90% success rate of EZ-IO insertion in 
our study is similar to the pooled data of the available studies 
(Table 2).6- 35 The failure to achieve IO access in our study was 
related to technical difficulties or erroneous location in half of the 
cases, indicating a need for improvement with additional train-
ing. 
Although humerai access is a recommended alternative in our 
EMS, proximal tibial access was used in ail but one patient. The ideal 
site of insertion of the IO device remains a matter of debate. Never-
theless, tibial access is frequently considered easier and faster, with 
Jess unsuccessful attempts and fewer dislodgements than with 
humerai access.22•34 It also minimises interference with resusci-
tation efforts in case ofCPR or airway management.19 On the other 
hand, the humerai site may be of great value in case of trauma, 
especially lower limb entrapment, injuries or burns. Our results 
are consistent with the high percentage of proximal tibial access 
described in the literature, although the humerus, distal radius and 
distal tibia are also occasionally described as insertion sites. 
A wide variety of medications was administered through the 
EZ-IO (Table 1 ). The high proportion of patients (60%) that received 
adrenaline in our study is consistent with the high proportion of 
patients (90%) with cardio-respiratory arrest. General anaesthesia 
induction was successfully performed in seven patients, a relatively 
high rate that may be explained by our physician-based setting. The 
seven cases where only fluids but no medication was administered 
through the EZ-IO included five cardiac arrest patients in which 
a rapid decision to discontinue the resuscitation was made; one 
patient had severe sepsis, and one had a severe traumatic brain 
injury. The literature review confirmed that the IO route can be 
used to administer a wide variety of drugs or fluids (Table 1 ). 
The survival rates at48 h and at discharge from the hospital were 
38% and 29%, respectively. No comparison with the available Jitera-
ture can be made, given the heterogeneous cohort and small patient 
numbers. Those rates were nevertheless collected and reported to 
allow a more precise interpretation of the complication rate. 
We did not identify any short-term complications of the IO 
access in our patients, or complications at discharge from the hospi-
tal in the survivors. Extravasation is the most commonly described 
immediate complication, but is generally inconsequential.32•36 
Osteomyelitis is a potential severe delayed complication, but 
its overall incidence remains low (0.6%).37 In the literature, 
osteomyelitis in children was correlated to high doses of 
adrenaline.38 Other complications include compartment syndrome 
and fractures, particularly with the semi-automatic devices.6•39·40 
Less frequent complications include gaseous embolism and fat 
embolism.41 .42 
The main limitation of our study is its specific, pre-hospital 
setting, which may not reflect the reality of other pre-hospital 
emergency medical services. This limitation is, however, inherent 
in ail pre-hospital studies. As our intraosseous indication protocol 
partially relies on a subjective assessment of the patient, a selec-
tion bias cannot be ruled out. Finally, the small size of the cohort 
and the non-randomised trial design do not permit the evaluation 
of the impact of the IO route on the patient's survival. 
5. Conclusion 
The EZ-IO device was shown to be effective in achievingvascular 
access in the pre-hospital setting. The 90% success rate, the local-
isation of insertion and the reasons for inserting an intraosseous 
device were similar to what is described in the literature. The 
intraosseous route can be used to administer a wide range of drugs 
and fluids. 
Further studies are needed to evaluate the impact of the 
intraosseous route, particularly on the patient's survival, and on 
the occurrence of delayed complications. 
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